US FDA The Food and Drug Administration is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments, responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter:link
Acetylcysteine (rINN An International Nonproprietary Name is the official non-proprietary or generic name given to a pharmaceutical substance, as designated by the World Health Organization (WHO)[citation needed]. The plethora of named proprietary preparations containing a given substance can lead to confusion about the identity of the active ingredient. INNs; pronounced /əˌsɛtəlˈsɪstiːn/), also known as N-acetylcysteine or N-acetyl-L-cysteine (abbreviated NAC), is a pharmaceutical drug A pharmaceutical drug, also referred to as medicine, medication or medicament, can be loosely defined as any chemical substance intended for use in the medical diagnosis, cure, treatment, or prevention of disease and nutritional supplement A dietary supplement, also known as food supplement or nutritional supplement, is a preparation intended to supplement the diet and provide nutrients, such as vitamins, minerals, fiber, fatty acids, or amino acids, that may be missing or may not be consumed in sufficient quantity in a person's diet. Some countries define dietary supplements as used primarily as a mucolytic agent and in the management of paracetamol US FDA:link (acetaminophen) overdose The term drug overdose describes the ingestion or application of a drug or other substance in quantities that are excessive. An overdose is widely considered harmful and dangerous as it can result in death. Other uses include sulfate repletion in conditions, such as autism, where cysteine and related sulfur amino acids may be depleted. [1]
Contents |
Trade names
In addition to being available as an over-the-counter nutritional supplement, acetylcysteine is also marketed under these trade names A trade name, also known as a trading name or a business name, is the name which a business trades under for commercial purposes, although its registered, legal name, used for contracts and other formal situations, may be another:
- ACC (Hexal AG Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufactures and markets off-patent medicines as well as pharmaceutical and biotechnological active ingredients)
- Acetadote (Cumberland Pharmaceuticals)
- Asist (Bilim Pharmaceuticals, Turkey)
- Lysox (Menarini The Menarini Group is an Italian pharmaceutical company. It was founded in Naples, Italy, in 1886, and has three divisions: Menarini Ricerche, Menarini Biotech and Menarini Diagnostics. It is committed to the search for pharmacological solutions for such therapeutic areas as cardiovascular diseases, oncology, pain/inflammation, asthma and anti-)
- Mucinac (Cipla, India)
- Mucolysin (Sandoz Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufactures and markets off-patent medicines as well as pharmaceutical and biotechnological active ingredients)
- Mucomelt (Venus Remedies, India)
- MUCOMIX (Samarth Life Sciences, India)
- Mucomyst (Bristol-Myers Squibb Bristol-Myers Squibb , often referred to as BMS, is a pharmaceutical company, headquarted in New York City. The company was formed in 1989, following the merger its predecessors Bristol-Myers and the Squibb Corporation. Squibb was founded in 1858 by Edward Robinson Squibb in Brooklyn, New York, while Bristol-Myers was founded in 1887 by William)
- Parvolex (GSK GlaxoSmithKline plc is a British pharmaceutical, biological, and healthcare company. GSK is the world's fourth largest pharmaceutical company after Johnson & Johnson, Pfizer, and Roche respectively by revenue; and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system,)
- Trebon N (Uni-pharma).
- Fluimucil (Zambon).
- Flumil (Pharmazam, Spain).
- Rheunac (Tree Of Life, Israel).
- Solmucaïne (IBSA, Switzerland).
- Nytex(Pharos,Indonesia)
Dosage forms
Acetylcysteine is available in different dosage forms for different indications:
- Solution for inhalation (Asist,Mucomyst, Mucosil) – inhaled for mucolytic therapy or ingested for nephroprotective effect (to protect the kidneys)
- IV Intravenous therapy or IV therapy is the giving of liquid substances directly into a vein. The word intravenous simply means "within a vein". Therapies administered intravenously are often called specialty pharmaceuticals. It is commonly referred to as a drip because many systems of administration employ a drip chamber, which prevents injection (Asist,Parvolex, Acetadote) – treatment of paracetamol/acetaminophen overdose
- Oral solution – various indications.
- Effervescent Tablets (200 mg) - Reolin (Hochland Pharma Germany), Solmucol (600 mg)(IBSA, Switzerland) and Mucinac (Cipla India).
- Ocular solution - for mucolytic therapy
- Sachet (600 mg) - Bilim Pharmaceuticals
- CysNAC (900mg) -- NeuroScience Inc.
The IV injection and inhalation preparations are, in general, prescription only, whereas the oral solution and the effervescent tablets are available over the counter Over-the-counter drugs are medicines that may be sold to a customer without a prescription from a health care professional, as compared to prescription drugs, which may only be sold to customers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they are products that are safe and in many countries.
Clinical use
Mucolytic therapy
Inhaled acetylcysteine is indicated for mucolytic ("mucus-dissolving") therapy as an adjuvant in respiratory conditions with excessive and/or thick mucus production. Such conditions include emphysema Emphysema is a long-term, progressive disease of the lung that primarily causes shortness of breath. In people with emphysema, the tissues necessary to support the physical shape and function of the lungs are destroyed. It is included in a group of diseases called chronic obstructive pulmonary disease or COPD . Emphysema is called an obstructive, bronchitis Bronchitis is inflammation of the mucous membranes of the bronchi, the airways that carry airflow from the trachea into the lungs. Bronchitis can be classified into two categories, acute and chronic, each of which has unique etiologies, pathologies, and therapies, tuberculosis Tuberculosis or TB is a common and often deadly infectious disease caused by various strains of mycobacteria, usually Mycobacterium tuberculosis in humans. Tuberculosis usually attacks the lungs but can also affect other parts of the body. It is spread through the air, when people who have the disease cough, sneeze, or spit. Most infections in, bronchiectasis Bronchiectasis is a disease state defined by localized, irreversible dilation of part of the bronchial tree. It is classified as an obstructive lung disease, along with emphysema, bronchitis and cystic fibrosis. Involved bronchi are dilated, inflamed, and easily collapsible, resulting in airflow obstruction and impaired clearance of secretions, amyloidosis In medicine, amyloidosis refers to a variety of conditions in which amyloid proteins are abnormally deposited in organs and/or tissues. A protein is described as being amyloid if, due to an alteration in its secondary structure, it takes on a particular aggregated insoluble form similar to the beta-pleated sheet. Symptoms vary widely depending, pneumonia Pneumonia is an inflammatory condition of the lung. It is often characterized as including inflammation of the parenchyma of the lung and abnormal alveolar filling with fluid (consolidation and exudation), cystic fibrosis Cystic Fibrosis is a common hereditary disease which affects the entire body, causing progressive disability and often early death. The name cystic fibrosis refers to the characteristic scarring (fibrosis) and cyst formation within the pancreas, first recognized in the 1930s. Difficulty breathing is the most serious symptom and results from and COPD Chronic obstructive pulmonary disease , also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive respiratory disease (CORD), refers to chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease refers to chronic bronchitis and emphysema, a pair of two commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs causing shortness of breath. In contrast to asthma, the limitation of airflow is poorly reversible and. It is also used post-operatively, as a diagnostic aid, and in tracheotomy Tracheotomy and tracheostomy are surgical procedures on the neck to open a direct airway through an incision in the trachea . They are performed by emergency physicians, and surgeons. Both surgical and percutaneous techniques are now widely used care. It may be considered ineffective in cystic fibrosis Cystic Fibrosis is a common hereditary disease which affects the entire body, causing progressive disability and often early death. The name cystic fibrosis refers to the characteristic scarring (fibrosis) and cyst formation within the pancreas, first recognized in the 1930s. Difficulty breathing is the most serious symptom and results from.[2] However, a recent paper in the Proceedings of the National Academy of Sciences reports that high-dose oral N-acetylcysteine modulates inflammation in cystic fibrosis and has the potential to counter the intertwined redox and inflammatory imbalances in CF.[3] Oral acetylcysteine may also be used as a mucolytic in less serious cases.
For this indication, acetylcysteine acts to reduce mucus viscosity by splitting disulfide bonds In chemistry, a disulfide bond is a covalent bond, usually derived by the coupling of two thiol groups. The linkage is also called an SS-bond or disulfide bridge. The overall connectivity is therefore R-S-S-R. The terminology is widely used in biochemistry. Formally the connection is called a persulfide, in analogy to its congener, a peroxide (R-O- linking proteins present in the mucus (mucoproteins).
Paracetamol (Acetaminophen) overdose
Main article: Paracetamol poisoningIntravenous acetylcysteine is indicated for the treatment of paracetamol US FDA:link (acetaminophen) overdose. When paracetamol is taken in large quantities, a minor metabolite called N-acetyl-p-benzoquinone imine (NAPQI) accumulates within the body. It is normally conjugated Xenobiotic metabolism is the set of metabolic pathways that modify the chemical structure of xenobiotics, which are compounds foreign to an organism's normal biochemistry, such as drugs and poisons. These pathways are a form of biotransformation present in all major groups of organisms, and are considered to be of ancient origin. These reactions by glutathione Glutathione is a tripeptide. It contains an unusual peptide linkage between the amine group of cysteine and the carboxyl group of the glutamate side chain. Glutathione, an antioxidant, helps protect cells from reactive oxygen species such as free radicals and peroxides, but when taken in excess, the body's glutathione reserves are not sufficient to inactivate the toxic NAPQI. This metabolite is then free to react with key hepatic enzymes, therefore damaging hepatocytes. This may lead to severe liver damage and even death by fulminant Fulminant is any event or process that occurs suddenly and quickly, and is intense and severe to the point of lethality, i.e., it has an explosive character. The word comes from Latin fulmināre, to strike with lightning. It is most frequently used in medicine, and there are several diseases described by this adjective: liver failure Liver failure is the inability of the liver to perform its normal synthetic and metabolic function as part of normal physiology. Two forms are recognised:.
For this indication, acetylcysteine acts to augment the glutathione reserves in the body and, together with glutathione, directly bind to toxic metabolites. These actions serve to protect hepatocytes A hepatocyte is a cell of the main tissue of the liver. Hepatocytes make up 70-80% of the liver's cytoplasmic mass. These cells are involved in: in the liver from NAPQI toxicity.
Although both IV and oral acetylcysteine are equally effective for this indication, oral administration is poorly tolerated, owing to the high doses required (due to low oral bioavailability In pharmacology, bioavailability is used to describe the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. By definition, when a medication is administered intravenously, its bioavailability is 100%. However, when a medication is administered via,[4]) very unpleasant taste and odour, and adverse effects An adverse drug reaction is an expression that describes harm associated with the use of given medications at a normal dose. The meaning of this expression differs from the meaning of "side effect", as this last expression might also imply that the effects can be beneficial. The study of ADRs is the concern of the field known as (particularly nausea and vomiting). Studies conducted by Baker and Dilger[5] suggest that the prior pharmacokinetic studies of N-acetylcysteine did not include Acetylation Acetylation describes a reaction that introduces an acetyl functional group into an organic compound. Deacetylation is the removal of the acetyl group as a reason for the low bioavailability In pharmacology, bioavailability is used to describe the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. By definition, when a medication is administered intravenously, its bioavailability is 100%. However, when a medication is administered via of N-acetylcysteine. In the research conducted by Baker,[5] it was concluded that oral N-acetylcysteine was identical in bioavailability to Cysteine precursors. (However, 3% to 6% of people given intravenous acetylcysteine show a severe, anaphylaxis Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. The term comes from the Greek words ανα ana and φύλαξις phylaxis (protection)-like allergic reaction, which may include extreme breathing difficulty (due to bronchospasm Bronchospasm or a bronchial spasm is a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release of substances from mast cells or basophils under the influence of anaphylatoxins. It causes difficulty in breathing which can be very mild to severe), a decrease in blood pressure In physiology and medicine, hypotension is abnormally low blood pressure. This is best understood as a physiologic state, rather than a disease. It is often associated with shock, though not necessarily indicative of it. Hypotension is the opposite of hypertension, which is high blood pressure. Blood pressure is the force of blood pushing against, rash, angioedema Angioedema is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues. It is very similar to urticaria, but urticaria, commonly known as hives, occurs in the upper dermis.. The term angioneurotic oedema was used for this condition in the belief that there was nervous system involvement but this is now thought, and sometimes also nausea and vomiting.[6] Repeated overdoses will cause the allergic reaction to progressively worsen.)
Several studies have found this anaphylaxis-like reaction to occur more often in people given IV acetylcysteine despite serum levels of paracetamol not high enough to be considered toxic.[7][8][9][10]
In some countries, a specific intravenous formulation does not exist to treat paracetamol US FDA:link overdose. In these cases, the formulation used for inhalation may be used intravenously.
Nephroprotective agent
Oral acetylcysteine is used for the prevention of radiocontrast Radiocontrast agents are a type of medical contrast medium used to improve the visibility of internal bodily structures in an X-ray based imaging techniques such as Computed tomography or Radiography (commonly known as X-ray imaging). Radiocontrast agents are typically iodine or barium compounds-induced nephropathy (a form of acute renal failure). Some studies show that prior administration of acetylcysteine markedly decreases (90%) radiocontrast nephropathy,[11] whereas others appear to cast doubt on its efficacy.[12][13] Worth considering is the newest data published in two papers in the New England Journal of Medicine and the Journal of the American Medical Association. The authors' conclusions in those papers were:
- "Intravenous and oral N-acetylcysteine may prevent contrast-medium–induced nephropathy with a dose-dependent effect in patients treated with primary angioplasty and may improve hospital outcome."[14]
- "Acetylcysteine protects patients with moderate chronic renal insufficiency from contrast-induced deterioration in renal function after coronary angiographic procedures, with minimal adverse effects and at a low cost"[15]
Acetylcysteine continues to be commonly used in individuals with renal impairment to prevent the precipitation of acute renal failure.[citation needed]
Microbiological use
N-Acetyl L-Cysteine can be used in Petroff's method i.e. liquefaction and decontamination of sputum, in preparation for diagnosis of tuberculosis.
Interstitial lung disease
Acetylcysteine is used in the treatment of interstitial lung disease to prevent disease progression.[16] [17][18][19]
Schizophrenia, bipolar disorder and depression
Acetylcysteine has been shown to reduce the symptoms of both schizophrenia[20] and bipolar disorder[21] in two placebo controlled trials conducted at Melbourne University. It is thought to act via increasing glutathione, although it increases glutamate, enhances neurogenesis and has anti-inflammatory properties[citation needed]. Replicatory trials in bipolar disorder, schizophrenia and depression are underway.
Investigational
The following uses have not been well-established or investigated:
- Evidence that NAC and other antioxidants can exert beneficial effects on pancreatic b-cell function in diabetes was published in a 1999 study. The authors conclude that a sufficient supply of antioxidants (NAC, vitamin C plus vitamin E, or both) may prevent or delay b-cell dysfunction in diabetes by providing protection against glucose toxicity.[22]
- NAC is undergoing clinical trials in the United States for the treatment of obsessive-compulsive disorder.[23] It is thought to counteract the glutamate hyperactivity in OCD.
- NAC has had anecdotal reports and some research suggesting efficacy in preventing nail biting[24]
- NAC has been shown to reduce cravings associated with chronic cocaine use in a study conducted at the Medical University of South Carolina[25][26]
- It may reduce the incidence of chronic obstructive pulmonary disease (COPD) exacerbations[27]
- In the treatment of AIDS, NAC has been shown to cause a "marked increase in immunological functions and plasma albumin concentrations"[28] Albumin concentration are inversely correlated with muscle wasting (cachexia), a condition associated with AIDS.
- An animal study indicates that acetylcysteine may decrease mortality associated with influenza [29]
- Animal studies suggest that NAC may help prevent noise-induced hearing loss.[30] A clinical trial to determine efficacy in preventing noise-induced sensorineural hearing loss in humans is currently (2006) being jointly conducted by the US Army [31] and US Navy [32]
- A human study of 262 primarily elderly individuals indicates that NAC may decrease influenza symptoms. In the study, 25% of virus-infected subjects who received NAC treatment developed symptoms, whereas 79% in the placebo group developed symptoms.[33]
- It has been suggested that NAC may help sufferers of Samter's triad by increasing levels of glutathione allowing faster breakdown of salicylates, though there is no evidence that it is of benefit [34]
- There are claims that acetylcysteine taken together with vitamin C and B1 can be used to prevent and relieve symptoms of veisalgia (hangover following ethanol (alcohol) consumption). The claimed mechanism is through scavenging of acetaldehyde, a toxic intermediate in the metabolism of ethanol.[35][36]
- It has been shown to help women with PCOS (polycystic ovary syndrome) to reduce insulin problems and possibly improve fertility.[37]
- Small studies have shown acetylcysteine to be of benefit to sufferers of blepharitis[citation needed] and has been shown to reduce ocular soreness caused by Sjogren's syndrome.[citation needed]
- Studies in mice models of Ataxia Telangictasia (ATM knockout) indicate that NAC prevents genomic instability and retards lymphomagenesis in these animals.[citation needed] Clinical trials in human AT patients are underway.[citation needed]
- It has been shown to help trichotillomania[38], a condition causing compulsive hair-pulling as well as compulsive nailbiting.
- Sulfur and sulfur-related amino acids are commonly depleted in autism[39]. Glutathione, which largely depends on cysteine for its formation, is also frequently depleted in autism[40], and may contribute to the heavy metal burden commonly found in autistic patients.
- Possible antidote for methyl mercury poisoning. It produced an acceleration of urinary methyl-mercury excretion in mice[41]
- It has been shown effective in Unverricht-Lundborg disease in an open trial in 4 patients. A marked decrease in myoclonus and some normalization of somatosensory evoked potentials with N -acetylcysteine treatment has been documented. http://emedicine.medscape.com/article/1153370-overview
- Small reduction of cell death in chemotherapy patients, due to reduction in oxidative stress. Reduced ROS and lipid peroxidation, and restored of antioxidant enzyme activities. http://www.biomedcentral.com/1471-2210/9/7
Complexing agent
N-Acetylcysteine has been used to complex palladium, to help it dissolve in water. This helps to remove palladium from drugs or precursors synthesized by palladium-coupling reactions.[42]
Chemistry
Acetylcysteine is the N-acetyl derivative of the amino acid L-cysteine, and is a precursor in the formation of the antioxidant glutathione in the body. The thiol (sulfhydryl) group confers antioxidant effects and is able to reduce free radicals.
Possible toxicity
Researchers at the University of Virginia reported in 2007 study using very large doses in a mouse model that acetylcysteine, which is found in many bodybuilding supplements, could potentially cause damage to the heart and lungs.[43] They found that acetylcysteine was metabolized to S-nitroso-N-acetylcysteine (SNOAC), which increased blood pressure in the lungs and right ventricle of the heart (pulmonary artery hypertension) in mice treated with acetylcysteine. The effect was similar to that observed following a 3-week exposure to an oxygen-deprived environment (chronic hypoxia). The authors also found that SNOAC induced a hypoxia-like response in the expression of several important genes both in vitro and in vivo.
The implications of these findings for long-term treatment with acetylcysteine have not yet been investigated. The dose used by Palmer and colleagues was dramatically higher than that used in humans;[43] nonetheless, the drug's effects on the hypoxic ventilatory response have been observed previously in human subjects at more moderate doses.[44]
See also
References
- ^ http://www.ncbi.nlm.nih.gov/pubmed/16825783
- ^ Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006.
- ^ Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB, Herzenberg LA (2006). "High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis". PNAS 103 (12): 4628–33. doi:10.1073/pnas.0511304103. PMID 16537378.
- ^ Borgström, L., B. Kågedal, and O. Paulsen (1986). "Pharmacokinetics of N-acetylcysteine 310 in man". Eur. J. Clin. Pharmacol. 31: 217–222. doi:10.1007/BF00606662.
- ^ a b Dilger, R. N., Baker, D. H. (2007). "Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine". Journal of Animal Science 85 (7): 1712. doi:10.2527/jas.2006-835. PMID 17371789.
- ^ Kanter MZ (2006). "Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning". American Journal of Health-System Pharmacy 63 (19): 1821. doi:10.2146/ajhp060050. PMID 16990628. http://www.ajhp.org/cgi/content/full/63/19/1821.
- ^ Dawson AH, Henry DA, McEwen J (March 1989). "Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning". Med. J. Aust. 150 (6): 329–31. PMID 2716644.
- ^ Bailey B, McGuigan MA (June 1998). "Management of anaphylactoid reactions to intravenous N-acetylcysteine". Ann Emerg Med 31 (6): 710–5. doi:10.1016/S0196-0644(98)70229-X. PMID 9624310.
- ^ Schmidt LE, Dalhoff K (January 2001). "Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning". Br J Clin Pharmacol 51 (1): 87–91. doi:10.1111/j.1365-2125.2001.01305.x. PMID 11167669.
- ^ Lynch RM, Robertson R (January 2004). "Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study". Accid Emerg Nurs 12 (1): 10–5. doi:10.1016/j.aaen.2003.07.001. PMID 14700565.
- ^ Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (July 2000). "Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine". N. Engl. J. Med. 343 (3): 180–4. doi:10.1056/NEJM200007203430304. PMID 10900277. http://content.nejm.org/cgi/content/full/343/3/180.
- ^ Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK (February 2004). "The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable". J. Am. Soc. Nephrol. 15 (2): 407–10. doi:10.1097/01.ASN.0000106780.14856.55. PMID 14747387. http://jasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=14747387.
- ^ Miner SE, Dzavik V, Nguyen-Ho P, et al. (October 2004). "N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up". Am. Heart J. 148 (4): 690–5. doi:10.1016/j.ahj.2004.05.015. PMID 15459602.
- ^ Marenzi G, Assanelli E, Marana I, et al. (June 2006). "N-acetylcysteine and contrast-induced nephropathy in primary angioplasty". N. Engl. J. Med. 354 (26): 2773–82. doi:10.1056/NEJMoa054209. PMID 16807414. http://content.nejm.org/cgi/content/full/354/26/2773.
- ^ Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF (2003). "Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial". JAMA the Journal of the American Medical Association 289 (5): 553. doi:10.1001/jama.289.5.553. PMID 12578487. http://jama.ama-assn.org/cgi/content/full/289/5/553.
- ^ Kasielski M, Nowak D (2001). "Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease". Respir Med 95: 448-456.
- ^ Grand jean EM, Berthet P, Ruffmann R, Leuenberger P (2000). "Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo controlled clinical trials.". Clin Ther 22: 209-221.
- ^ Stey C, Steurer J, Bachmann S, Medici TC, Tramer MR (2000). "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review [In Process Citation]". Eur Respir J 16: 253-262.
- ^ Poole PJ, Black PN (2001). "Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review". BMJ 322 (3): 1271-1274.
- ^ Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI (September 2008). "N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial". Biol. Psychiatry 64 (5): 361–8. doi:10.1016/j.biopsych.2008.03.004. PMID 18436195. http://linkinghub.elsevier.com/retrieve/pii/S0006-3223(08)00270-9.
- ^ Berk M, Copolov DL, Dean O, et al. (September 2008). "N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial". Biol. Psychiatry 64 (6): 468–75. doi:10.1016/j.biopsych.2008.04.022. PMID 18534556.
- ^ Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, et al. (1999). "Beneficial Effects of Antioxidants in Diabetes: Possible Protection of Pancreatic b-cells Against Glucose Toxicity". Diabetes 48 (12): 2398–2406. doi:10.2337/diabetes.48.12.2398. PMID 10580429. http://diabetes.diabetesjournals.org/cgi/reprint/48/12/2398.pdf.
- ^ N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder - Full Text View - ClinicalTrials.gov
- ^ Berk M et al. Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting. CNS Spectr. 2009 Jul;14(7):357-60.
- ^ Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ (March 2007). "An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study". Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2): 389–94. doi:10.1016/j.pnpbp.2006.10.001. PMID 17113207.
- ^ LaRowe SD, Myrick H, Hedden S, et al. (July 2007). "Is cocaine desire reduced by N-acetylcysteine?". Am J Psychiatry 164 (7): 1115–7. doi:10.1176/appi.ajp.164.7.1115. PMID 17606664.
- ^ Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM (1999). "N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD". Respiration 66 (6): 495–500. doi:10.1159/000029447. PMID 10575333. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=res66495.
- ^ Breitkreutz R, Pittack N, Nebe CT, et al. (2000). "Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials". J. Mol. Med. 78 (1): 55–62. doi:10.1007/s001090050382. PMID 10759030.
- ^ Ungheri D, Pisani C, Sanson G, et al. (2000). "Protective effect of N-acetylcysteine in a model of influenza infection in mice". Int J Immunopathol Pharmacol 13 (3): 123–128. PMID 12657201.
- ^ Kopke R, Bielefeld E, Liu J, et al. (March 2005). "Prevention of impulse noise-induced hearing loss with antioxidants". Acta Otolaryngol. 125 (3): 235–43. doi:10.1080/00016480410023038. PMID 15966690.
- ^ {{Acker-Mills, B., Robinette, M., LaPrath, A., and Kopke, R. (December, 2004). Effects of N-acetylcysteine on otoacoustic emissions following noise exposure. Proceedings of the 2004 Army Science Conference, Orlando, Florida. AD Number: ADA433105
- ^[citation needed]
- ^ S. De Flora, C. Grassi, L. Carati (1997). "Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment". Eur Respir J 10 (7): 1535–1541. doi:10.1183/09031936.97.10071535. PMID 9230243. http://erj.ersjournals.com/cgi/content/abstract/10/7/1535.
- ^ Bachert C, Hörmann K, Mösges R, et al. (March 2003). "An update on the diagnosis and treatment of sinusitis and nasal polyposis". Allergy 58 (3): 176–91. doi:10.1034/j.1398-9995.2003.02172.x. PMID 12653791.
- ^ Fawkes, SW CERI: Living with Alcohol Smart Drug News 1996 Dec 13
- ^ Resat Ozaras, Veysel Tahan, Seval Aydin, Hafize Uzun, Safiye Kaya, Hakan Senturk. N-acetylcysteine attenuates alcohol-induced oxidative stess in rats World Journal of Gastroenterology 2003 Apr 15
- ^ Fulghesu AM, Ciampelli M, Muzj G, et al. (June 2002). "N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome". Fertil. Steril. 77 (6): 1128–35. doi:10.1016/S0015-0282(02)03133-3. PMID 12057717.
- ^ Grant J, et al (2009). "N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania". Archives of General Psychiatry 66 (7): 756–63. doi:10.1001/archgenpsychiatry.2009.60. PMID 19581567.
- ^ http://www.ncbi.nlm.nih.gov/pubmed/16825783
- ^ http://www.ncbi.nlm.nih.gov/pubmed/20107587
- ^ N Ballatori, M W Lieberman, and W Wang (1998). "N-acetylcysteine as an antidote in methylmercury poisoning.". Environ Health Perspect 106(5): 267–71.
- ^ Garrett, Christine E., Christine E. Garrett; Kapa Prasad; Prasad, Kapa (2004). "The Art of Meeting Palladium Specifications in Active Pharmaceutical Ingredients Produced by Pd-Catalyzed Reactions". Advanced Synthesis & Catalysis 346 (8): 889–900. doi:10.1002/adsc.200404071.
- ^ a b Palmer LA, Doctor A, Chhabra P, et al. (September 2007). "S-nitrosothiols signal hypoxia-mimetic vascular pathology". J. Clin. Invest. 117 (9): 2592–601. doi:10.1172/JCI29444. PMID 17786245.
- ^ Hildebrandt W, Alexander S, Bärtsch P, Dröge W (March 2002). "Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity". Blood 99 (5): 1552–5. doi:10.1182/blood.V99.5.1552. PMID 11861267. http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=11861267.
- British National Formulary 55, March 2008; ISBN 978 085369 776 3
External links
- U.S. National Library of Medicine: Drug Information Portal - Acetylcysteine
- Research based information on Acetylcysteine as a nutritional supplement
|
|||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Categories: Antioxidants | Antidotes | Thiols | Amino acid derivatives | World Health Organization essential medicines | Excipients | Treatment of bipolar disorder | Acetamides
|
Tue, 01 Jun 2010 17:54:31 GMT+00:00
Journal of Bone and Joint Surgery (subscription) 70 demonstrated that treatment of injured articular cartilage explants with N- acetylcysteine can decrease the amount of chondrocyte death that would occur ...
498px x 343px | 63.90kB
[source page]
Plasma paracetamol concentrations in relation to time after overdosage as a guide to prognosis From guidelines agreed by National Poisons Centres June 1995 Parvolex is indicated in patients
editors
ue, 20 May 2008 17:06:24 GM
Because it is readily absorbed and rapidly metabolized to glutathione, N-. Acetyl Cysteine. (NAC) is the glutathione building block most favored by healthcare practitioners. In the case of an acetaminophen overdose, NAC is administered by ...
Q. drug -drug interaction
Asked by OaCE U - Mon Nov 17 18:22:36 2008 - - 1 Answers - 0 Comments
A. Low to none.
Answered by Mr. Peachy - Mon Nov 17 20:43:43 2008


